Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRPS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IBSP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPYS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DPYSL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00313 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
COL14A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930476 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NATD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLCO4A1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on